Holen Sie sich die Stockscreener-App
96.85
0.77%
0.58
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RVTY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$96.27
Offen:
$95.8
24-Stunden-Volumen:
667.02K
Relative Volume:
0.47
Marktkapitalisierung:
$10.98B
Einnahmen:
$2.77B
Nettoeinkommen (Verlust:
$286.61M
KGV:
41.21
EPS:
2.35
Netto-Cashflow:
$524.11M
1W Leistung:
-6.28%
1M Leistung:
+6.54%
6M Leistung:
+3.03%
1J Leistung:
-15.46%
1-Tages-Spanne:
$95.80
$100.16
1-Wochen-Bereich:
$95.44
$104.44
52-Wochen-Spanne:
$81.36
$128.28
Revvity Inc Stock (RVTY) Company Profile
Firmenname
Revvity Inc
Sektor
Branche
Telefon
781-663-6900
Adresse
77 4TH AVENUE, WALTHAM
Vergleichen Sie RVTY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
96.81 | 10.91B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
566.19 | 214.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
223.16 | 158.72B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
688.91 | 55.35B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
137.00 | 39.40B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
223.12 | 37.75B | 15.90B | 1.28B | 2.21B | 7.2842 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Goldman | Neutral |
| 2025-10-16 | Eingeleitet | Guggenheim | Neutral |
| 2025-05-01 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-10 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-08 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-23 | Fortgesetzt | Goldman | Buy |
Alle ansehen
Revvity Inc Aktie (RVTY) Neueste Nachrichten
Revvity to launch AI models-as-a-service for scientific discovery - Investing.com Nigeria
Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials D - pharmiweb.com
Revvity Introduces New AI Service for Molecular, Materials Design - marketscreener.com
Revvity unveils AI-powered Signals Xynthetica to accelerate molecular and materials design - Indian Pharma Post
Barclays Maintains Revvity (RVTY) Overweight Recommendation - Nasdaq
Revvity Shares Fall After BofA Downgrade - marketscreener.com
How is Revvity's stock performance compared to other health care stocks? - MSN
Revvity stock rating downgraded to Neutral by BofA Securities - Investing.com South Africa
Revvity (NYSE:RVTY) Lowered to "Neutral" Rating by Bank of America - MarketBeat
Barclays Adjusts Price Target on Revvity to $115 From $105, Maintains Overweight Rating - marketscreener.com
Wells Fargo Adjusts Price Target on Revvity to $107 From $102, Maintains Equalweight Rating - marketscreener.com
How Is Revvity's Stock Performance Compared to Other Health Care Stocks? - inkl
EdgePoint Investment Group Inc. Boosts Stock Position in Revvity Inc. $RVTY - MarketBeat
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
Federated Hermes Inc. Cuts Position in Revvity Inc. $RVTY - MarketBeat
The Goldman Sachs Group Begins Coverage on Revvity (NYSE:RVTY) - MarketBeat
Goldman Sachs Initiates Coverage of Revvity (RVTY) with Neutral Recommendation - Nasdaq
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Goldman Sachs Initiates Coverage on RVTY with Neutral Rating | R - GuruFocus
Amundi Boosts Stock Position in Revvity Inc. $RVTY - MarketBeat
Goldman Sachs initiates coverage on Revvity stock with Neutral rating By Investing.com - Investing.com Canada
Goldman Sachs initiates coverage on Revvity stock with Neutral rating - Investing.com India
Revvity Inc. $RVTY Position Reduced by 2Xideas AG - MarketBeat
Invesco Ltd. Acquires 452,343 Shares of Revvity Inc. $RVTY - MarketBeat
Bull Bear: Is Revvity Inc stock a defensive play in 2025Options Play & Community Consensus Trade Signals - BỘ NỘI VỤ
Bollard Group LLC Purchases Shares of 18,439 Revvity Inc. $RVTY - MarketBeat
Is There An Opportunity With Revvity, Inc.'s (NYSE:RVTY) 22% Undervaluation? - 富途牛牛
Fisher Asset Management LLC Decreases Stock Position in Revvity Inc. $RVTY - MarketBeat
Revvity Inc. (NYSE:RVTY) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Will Revvity Inc. stock hit analyst forecastsJuly 2025 Gainers & Free Reliable Trade Execution Plans - Newser
Revvity Inc. $RVTY Shares Acquired by Russell Investments Group Ltd. - MarketBeat
Why Revvity Inc. stock is a strong buy callTrade Signal Summary & Free Fast Gain Swing Trade Alerts - Newser
Why Revvity Inc. stock is trending on social mediaWeekly Stock Report & Fast Moving Stock Watchlists - Newser
Why Revvity Inc. stock remains stable2025 Sector Review & Low Risk High Win Rate Picks - Newser
Jim Cramer Highlights That “Revvity’s the Cheapest in the Group” - Insider Monkey
Revvity to acquire ACD/Labs - MSN
Norges Bank Takes Position in Revvity Inc. $RVTY - MarketBeat
Korea Investment CORP Has $6.89 Million Position in Revvity Inc. $RVTY - MarketBeat
Revvity Inc. $RVTY Shares Sold by JPMorgan Chase & Co. - MarketBeat
How Revvity Inc. stock reacts to global recession fearsMarket Weekly Review & High Conviction Buy Zone Picks - Newser
Can Revvity Inc. stock beat analyst consensus2025 Risk Factors & Expert Curated Trade Setups - Newser
Can Revvity Inc. (PKN) stock survive global slowdownJuly 2025 Outlook & Daily Entry Point Alerts - Newser
Can Revvity Inc. (PKN) stock resist broad market declines2025 Analyst Calls & Low Volatility Stock Suggestions - Newser
Jim Cramer Recently Discussed These 9 Stocks - Insider Monkey
RVTY: Life sciences, software, and diagnostics show growth, with China stabilizing and margins set to improve - TradingView — Track All Markets
Hsbc Holdings PLC Acquires 108,919 Shares of Revvity Inc. $RVTY - MarketBeat
Is Revvity Inc. (PKN) stock safe for risk averse investors2025 Institutional Moves & Verified Entry Point Signals - Newser
Revvity Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
Neuberger Berman Group LLC Sells 4,047 Shares of Revvity Inc. $RVTY - MarketBeat
(RVTY) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Finanzdaten der Revvity Inc-Aktie (RVTY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):